Tirzepatide Near Me: Clinic Prices by State + Online Options
Any US pharmacy can fill a tirzepatide prescription; ask your local pharmacy to order it if it is not on the shelf. The lowest self-pay price is $299 a month, and the lowest pharmacy cash price we found is $299 a month at Walmart Pharmacy.
- Lowest self-pay
- $299 a month
- Telehealth from, all in
- $373 a month
- Prescription
- Required
- Shortage
- Resolved
Zepbound: key facts
The half-life is 5 to 6 days. By 5.5 d, half is gone, and after five half-lives (27.5 d), about 3% remains.
In SURMOUNT-1 at 72 weeks, the percentage of body weight was 20.9%, compared with 3.1% on placebo.
In US dollars, monthly prices include the manufacturer's list price and self-pay offers. Every figure comes from the manufacturer's price page.
Sources: FDA label (DailyMed), Eli Lilly 1 2, cnbc.com.
All the legitimate ways to get tirzepatide, in order
| Route | Who it is for | What you pay |
|---|---|---|
| Mounjaro: Insurance and the savings card through your doctor | Commercial insurance that covers it | From $25 for a fill of up to 3 months |
| Zepbound: Insurance and the savings card through your doctor | Commercial insurance that covers it | From $25 for a fill of up to 3 months |
| Zepbound: LillyDirect: LillyDirect vial or KwikPen 2.5 mg | Anyone with a prescription, no insurance needed | $299 a month |
| Zepbound: TrumpRx listing (vial, starting) | Self-pay only | $299 a month |
| Zepbound: Walmart Pharmacy: LillyDirect self-pay (lowest dose) | Cash at the pharmacy counter | $299 a month |
| Telehealth: WeightWatchers Med+, Zepbound (self-pay) | Online visit, medicine shipped | $373 a month all in |
| Compounded copy: Mochi Health | Not FDA approved; ranked last for that reason | $90 a month |
Prices checked November 2026. Each listed price links to its source page.
Sources: pricinginfo.lilly.com, mounjaro.lilly.com, GoodRx, zepbound.lilly.com.
Who qualifies
Every GLP-1 sold in the US requires a prescription. Prescribers write it for one use approved on the label:
- Mounjaro: It lowers blood sugar for adults and children 10 and older with type 2 diabetes when used with diet and exercise.
- Mounjaro: For adults with type 2 diabetes at high risk, it reduces the chance of heart attack, stroke, or heart-related death.
- For adults with obesity or those who are overweight with a weight-related condition, Zepbound supports weight loss and long-term weight maintenance with diet and activity.
- Zepbound: It treats moderate to severe obstructive sleep apnea in adults with obesity.
Source: FDA label (DailyMed).
Telehealth compared
| Program | Medicine option | Medicine price | Membership | All in |
|---|---|---|---|---|
 WeightWatchers Med+ | Zepbound (self-pay) | $299 a month | $74 a month | $373 a month |
 Ro | Zepbound KwikPen, starting dose | $299 a month | $149 a month | $448 a month |
 Hims & Hers | Zepbound | $1,899 a month | $149 a month after first month | $2,048 a month |
| Hims & Hers | Mounjaro | $1,899 a month | $149 a month after first month | $2,048 a month |
 Mochi Health | Compounded tirzepatide (not FDA approved) | $90 a month | $79 a month after free first month | $169 a month |
 Found | Compounded GLP-1 plan (not FDA approved) | $99 a month | $169 a month cash | $268 a month |
 Noom Med | Not FDA approved: compounded GLP-1 plus GIP in the GLP-1Rx Plus Program | after the first 4 weeks, $299 a month, billed quarterly | Not listed | Included |
Every price comes from that program's own pricing page. We do not earn money from any of them.
Sources: weightwatchers.com, ro.co, hims.com, joinmochi.com.
Shortage status
Tirzepatide: Shortage resolved. On December 19, 2024, the FDA confirmed this.
- The FDA shortage list showed it for the first time on December 15, 2022
- Shortage resolved: December 19, 2024
- Compounding copies had to end at state pharmacies by February 18, 2025
- Outsourcing facilities had to stop by March 19, 2025
Source: FDA.
Scam signals
- No prescription needed: a seller that skips it is not a licensed US pharmacy.
- For self-pay, the lowest price for a brand is $299 each month. That is far below what the manufacturer charges.
- A compounded drug sold as the brand is not approved. It is not Ozempic, Wegovy, Mounjaro or Zepbound.
- Claims of being the same as the brand: FDA sent 30 warning letters to telehealth companies over misleading claims.
- Harm reports: more than 730 adverse event reports linked to compounded tirzepatide have been logged by the FDA.
- A monthly price without the medicine itself led one program to face FTC action. For details, see the NextMed review.
Sources: pricinginfo.lilly.com, mounjaro.lilly.com, GoodRx, zepbound.lilly.com.
Find it in your state
- Hims & Hers: Coverage does not include some of the 50 states
- Noom Med: Coverage is unavailable in some of the 50 states
- NovoCare Pharmacy: Coverage includes 50 states, DC, Puerto Rico through its delivery network
Medicaid rules have the most effect on the route you take Medicaid rules affect the route more than any other factor. Today, 10 state Medicaid programs cover GLP-1s for weight loss. Select your state to view its drug list and prior authorization rules:
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming